InvestorsHub Logo
Followers 7
Posts 223
Boards Moderated 1
Alias Born 01/12/2015

Re: None

Thursday, 08/10/2017 12:27:08 PM

Thursday, August 10, 2017 12:27:08 PM

Post# of 37455
$MFST Medifirst Solutions Signs Distribution Agreement

Comprehensive FPS Profile link including EVERYTHING you want to know on MFST including recent updates, PR's, Quote, stock price, ETC:
http://www.frontpagestocks.com/medifirst-solutions-mfst/

FREEHOLD, NJ--(Marketwired - Aug 4, 2017) - MEDIFIRST SOLUTIONS, INC. ( OTC PINK : MFST ) (the "Company" or "Medifirst"), a provider of innovative laser technology with its FDA 510(k) cleared Infrared Time Machine TTML-8102000 Laser Thermal Therapeutic Device, is pleased to announce that it has signed a distribution agreement with an international distribution company based in the Middle East that has the rights for the following territories: Lebanon, Kuwait, Saudi Arabia, United Arab Emirates, Bahrain, Qatar, Oman, Jordan and Iraq. During the term of this Agreement, the distributor has the first-right-of-refusal to expand the territory in order to distribute the products on an exclusive basis in Egypt, Cyprus and Turkey. Its distribution arm includes established medical distribution companies in the region: Medica Group, Gulf Drug, and Arabian Ethicals.
https://finance.yahoo.com/news/medifirst-solutions-signs-distribution-agreement-180717583.html


Medifirst Solutions, Inc. (OTC Trading Symbol: MFST)
Website: www.medifirst.com

MFST in response to its Premarket Notification 510(k) submission for The Time Machine Series Laser, received clearance from the U.S. Food and Drug Administration to market its infrared Time Machine TTML-8102000 Laser Thermal Therapeutic Device. The Time Machine Series Lasers Model TTML-8102000 - 810/830nm is intended for use in temporary relief of minor muscle and joint pain, stiffness, minor arthritis pain, muscle spasm, temporary increase in local blood circulation and temporary relaxation of muscles by means of topical elevated tissue temperature from infrared spectral emissions. Due to the decrease of inflammation, patients have seen immediate aesthetic improvements as well, such as in scar healing and incisions. The hand-held laser device, with pin-point accuracy, often gives patients immediate results with no redness, swelling or down-time. This unique laser device offers medical professionals an affordable and effective tool to enhance their treatment protocols for their patients and provide new revenue streams for their practice. The laser division will be operated out of Medifirst's wholly owned subsidiary, Medical Lasers Manufacturer

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.